Celleron Therapeutics

Developing drugs targeting epigenetic control for the treatment of cancer.

placeAbingdon, England, United Kingdom calendar_todayFounded 2004 groups11 employees language cellerontherapeutics.com

Registered entities

Innovation

6 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 209 times.

YearFilings
20192
20201
20212
20222
20232
20241
20252
20261

Investor mix

6 investors on record; lead investors include NHN Investment, IMM Investment, KTB Network, Korea Investment Holdings.

Investor typeCountShare
Venture capital233%
Accelerator & incubator117%
Bank & private debt117%
Other / undisclosed233%
Coming soon